Share this article
Share this article
NAPLES, Fla., Feb. 23, 2021 /PRNewswire/ Eight final honorees will divide $200,000 for meritorious entries in Alzheimer s Germ Quest s $1 Million Challenge , which lasted three years, ending December 31, 2020, says Leslie Norins, MD, PhD, FIDSA (Emeritus), CEO. However, nobody provided persuasive-enough evidence that a particular infectious agent was the sole cause of Alzheimer s disease, so the grand prize of $1 million will not be awarded. Summary results are posted online.
The challenge initially attracted 81 would-be entrants, of whom 40 were authorized to submit formal entries. Eight did so.
The finalists were Ruth Itzhaki, Manchester; Hugo Lovheim, Umea, Sweden; Richard Lathe, Edinburgh; Rima McCleod, Chicago, Tom Dowd, Wisconsin; Alan MacDonald, Naples; May Bedoun, Baltimore, and Steven Dominy, San Francisco.
Share this article
Share this article
NAPLES, Fla., Feb. 16, 2021 /PRNewswire/ The advocacy group Us Against Alzheimer s (UsA2) did not reveal in its January 19 letter to the FDA urging approval of aducanumab for Alzheimer s disease it had received monies from the drug s maker, Biogen, says Leslie Norins, MD, PhD, CEO of Alzheimer s Germ Quest.
For example, Biogen and its co-venturer, Esai, were both listed as Premier sponsors of the virtual Alzheimer s symposium presented by UsA2 in November 2020. The premier designation was ranked even higher than platinum, but its cost was not given.
This is similar veiling to that of the Alzheimer s Association letter supporting approval of the same drug; significant contributions possibly millions of dollars to the association from Biogen and Esai were not disclosed, says Dr. Norins.
IDSA Foundation Announces More Than $1 Million in Grant Funds for Researchers Linking Infectious Agents in Alzheimerâs Disease
Newswise ARLINGTON, Va. (January 12, 2021) – Ten researchers who are exploring the link between an infectious agent and Alzheimer’s disease have each been awarded $100,000 research grants through the IDSA Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program. Since the program was established in 2018, the IDSA Foundation has provided more than $600,000 to seven researchers, making the 2020 awardees the largest recipient pool to date. The program will provide an additional pilot grant of $8,000 to begin research and initial data collection for a dementia study in Uganda.